Approval · Notice of Compliance 5402 · 1994
ALKERAN: Notice of Compliance 5402
Issued April 27, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5402
- Date
- April 27, 1994
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength, new dosage form (kit)
- Therapeutic class
- Antineoplastic (alkylating) agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALKERAN | 02087286 | Marketed |
Medicinal ingredients
- MELPHALAN HCL 50 MG per VIAL